Michael Scolaro

Michael Scolaro

Aug 22, 2017

Group 6 Copy 37
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Part 2: Can low carbohydrate ketogenic diets inhibit cancers?

    We've identified that ketone bodies, i.e. fuels in the bloodstream that result from a very low carbohydrate...

    Target-based drug discovery for coronavirus disease 2019

    Therapeutics in any modality to combat Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infections...

    Finding a Cure for Mitochondrial DNA Diseases through COX2 Variations to Restore Cell Function

    Inherited and acquired mutations in the mitochondrial DNA can lead to several debilitating diseases, including...

    Backer Badge Funded